REGISTER
ERS 2026 Awards: Six Chinese Scholars Among Best Abstract Winners
Six of 14 Best Assembly Abstract Award recipients at ERS 2026 are based in China: Jiarun Lin (Nanfang Hospital, Southern Medical University), Bingzhang Zou (China-Japan Friendship Hospital), Tao Chen (Peking Union Medical College Hospital), Hong Luo and Sisi Dai (West China Hospital, Sichuan University), and Tian Jiang (Zhongshan Hospital, Fudan University). Their work covers critical care, basic science, infection, thoracic oncology, interstitial lung disease, and pulmonary vascular disease.

The European Respiratory Society (ERS) 2026 Annual Congress is set to open the day after the recipients of this years’ awards were announced. According to a release from MedJ’s Respiratory Channel, the ERS Congress is one of the major international meetings in respiratory medicine.

This year’s awards recognize contributions across clinical care, research, education, and advocacy in the global respiratory community.

Fig. 1. MedJ on Site at the ERS 2026 Congress

Best Assembly Abstract Awards

The Best Assembly Abstract Awards are the ERS’s highest annual recognition for abstracts. Each of the ERS’s 14 scientific assemblies selects one winning abstract from its submissions.

Six of this year’s 14 recipients are based in China:

- Jiarun Lin, Nanfang Hospital, Southern Medical University

- Bingzhang Zou, China-Japan Friendship Hospital

- Tao Chen, Peking Union Medical College Hospital

- Hong Luo, West China Hospital, Sichuan University

- Sisi Dai, West China Hospital, Sichuan University

- Tian Jiang, Zhongshan Hospital, Fudan University

Their research covers critical care, basic science, infection, thoracic oncology, interstitial lung disease, and pulmonary vascular disease.

The complete list of award winners is as follows:

Assembly

Group Name

Winner

Country/Region

Abstract Title (English)

Assembly 1

Respiratory Clinical Care and Physiology

Jia-Run Lin

China

Plasma Proteomic Profiling Identifies Pulmonary Surfactant Protein B (PSPB) as a Diagnostic Biomarker for Checkpoint Inhibitor Pneumonitis

Assembly 2

Respiratory Intensive Care

Muhammad Hashim Naseer

United Kingdom

Standard stepwise compared to accelerated weaning from NIV in ECOPD directed by the NIV outcome score: a randomised controlled trial

Assembly 3

Basic and Translational Sciences

Tian Jiang

China

A Metabolic-Epigenetic Switch via SRSF4 K95 Laxylation Reprograms SMPD1 Alternative Splicing to Drive Acute Lung Injury

Assembly 4

Sleep-Disordered Breathing

Sebastien Bailly

France

Association of positive airway pressure adherence with mortality and cardiovascular events in high vs low risk obstructive sleep apnoea

Assembly 5

Airway Diseases, Asthma, COPD, and Chronic Cough

George W. Nava

United Kingdom

Structural brain imaging in biologic naive T2-high severe asthma, baseline data from the CONTENTed study

Assembly 6

Epidemiology and Environment

Alan Dominguez

Spain

Prenatal exposure to air pollution and foetal lung maturity assessed using quantitative ultrasound texture analysis

Assembly 7

Paediatrics

Punitkumar Makani

Netherlands

More structural lung abnormalities in young adults born prematurely in the post-surfactant era: results from an Australian birth cohort

Assembly 8

Thoracic Surgery and Transplantation

Balin Ozsoy

Belgium

Single-nucleus RNA sequencing uncovers dynamic endothelial heterogeneity and increasing capillary inflammation during human lung ischemia-reperfusion injury

Assembly 9

Allied Respiratory Professionals

Jenny Nilsson

Sweden

Evaluation of a digital self-management system and its effects on medication adherence

Assembly 10

Respiratory Infections

Hong Luo

China

Co-occurrence patterns and related risk factors of chronic obstructive pulmonary disease and tuberculosis across 204 countries and territories: a spatial correspondence and systematic analysis

Assembly 11

Thoracic Oncology

Sisi Dai

China

Systemic Activation and Tissue Infiltration of CD8+CD3CR1+ T cells in Non-Small Cell Lung Cancer Treated with Neoadjuvant Immune Checkpoint Blockade

Assembly 12

Interstitial Lung Diseases

Tao Chen

China

Prednisone combined with mycophenolate mofetil is effective for patients with idiopathic non-specific interstitial pneumonia

Assembly 13

Pulmonary Vascular Diseases

Bingzhang Zou

China

Chronic Modifiable Exposures Account for Nearly Half of Venous Thromboembolism Risk: An Exposome-Wide Association Study in the UK Biobank

Assembly 14

Clinical Techniques, Imaging and Endoscopy

Arschang Valipour

Austria

Airway Scaffolds for Emphysema-Related Hyperinflation: 12-month Outcomes

Fig. 2. ERS 2026 Award Recipients Announced on Site

ERS Lifetime Achievement Awards

This award is presented to senior scientists who have dedicated their lives to respiratory medicine and are highly esteemed internationally. This year’s recipients span pediatrics, respiratory healthcare professionals, pulmonary vascular disease, clinical technology, and science in developing countries. The list is as follows:

Award Category

Award Winner

Paediatrics

Prof. Matthias GRIese

Allied Respiratory Professionals

Prof. Sally Singh

Pulmonary Vascular Diseases

Prof. Marion Delcroix

Clinical Techniques, Imaging and Endoscopy

Prof. Venerino Poletti

Scientifically Developing Countries (SDC)

Prof. Carlos Luna

Fig. 3. ERS 2026 Lifetime Achievement Award Recipients Announced on site

Other Awards

- ERS Early Career Member Award: Amy Hai Yan Chan

- ERS Sadoul Lecture Award: Anne Chang

- ERS Advocacy Lifetime Achievement Award: Luke J. Clancy

- ERS Teaching Award: Apostolos Bossios, Esther Irene Schwarz

- ERS Education Award: Anita Simonds

- ERS Congress Chair Award: Alvar Agusti

- ERS Presidential Award: Sylvia Hartl

Summary:

From the Lifetime Achievement Award to the Best Abstract Awards, this year’s ERS awards comprehensively reflect the vibrant ecosystem of respiratory medicine—from academic foundations to innovative breakthroughs.

Chinese scholars won six Best Abstract Awards, a testament to the balanced development and sustained efforts of China’s domestic respiratory discipline across three key domains: basic research, clinical translation, and epidemiology. Moving from “participating globally” to “contributing globally,” and now to “leading globally,” Chinese respiratory researchers are writing a new chapter on the international stage through robust scientific output and an increasingly influential academic voice!

0
0
Loading